DEC 23, 2017 5:50 AM PST

Circulating Immune Cells Accidentally Promote Crohn's Disease

WRITTEN BY: Kara Marker

Immune cells that travel from tissue to tissue need to be able to adapt to different tissues, including the high-acidity conditions of the gut necessary for digestion and protection from microbes that enter the body through food. From the Scripps Research Institute, scientists investigate what goes wrong when T helper 17 (TH17) cells fail to adapt.

High magnification micrograph of Crohn's disease in the colon. Credit: Wikimedia user Nephron

TH17 cells produce an inflammatory chemical messenger called interleukin 17 (IL-17), which is helpful during pathogenic infections but harmful during healthy conditions. When and where TH17 cells release IL-17 depends on how they adapt to different tissues, so it’s easy to see how important it is for TH17 cells to adapt to tissue, especially in the gastrointestinal (GI) tract.

Lead researcher Mark Sundrud, PhD, hopes he and his team might learn to target areas like the GI tract specifically to dampen inflammation “instead of just generally suppressing the entire immune system."

TH17 cells, as they are involved in both immune defense and promotion of chronic inflammation, are often implicated in Crohn’s disease, an inflammatory bowel disease in the GI tract usually found at the end of the small intestine, an area called the ileum. Crohn’s disease affects about 700,000 people in the United States.

Sundrud’s new study builds off of previous research that found that TH17 cells boost expression of a gene called MDR1 as they enter the intestine, shown in human tissue samples. MDR1 is a protein that “transports chemotherapeutic drugs out of tumor cells,” but what does it do in the context of TH17 immune cells? Do TH17 use “different tools” to adapt to different tissues? Do they activate different genes in different places?

They found that MDR1 protects TH17 cells in the gut from bile acids, helping TH17 cells that need to adapt to the acidity of the gut. When they don’t, Crohn’s disease can develop.

Using a mouse model genetically modified to illustrate the importance of MDR1 in TH17 adaption in the gut, researchers saw that there was increased expression of the gene as TH17 cells enter the gut in mice with a normal MDR1 gene. But in mice who lacked the ability to express MDR1, TH17 cells were exposed to severe cell damage and led to Crohn’s disease.

Using human blood samples, researchers discovered a portion of human patients with Crohn’s disease who also had “severely impaired MDR1 expression.” A class of drugs called bile acid sequestrants brought T cell function back to normal and successfully treated the developing Crohn’s disease.

This study, published in the journal Immunity - both Identifies a cause of Crohn’s disease - cell damage from missing MDR1 expression - and provides a new treatment option for Crohn’s patients with this particular issue.

Sources: Immunological Reviews, Crohn’s & Colitis, Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, ...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently in ...
MAR 03, 2020
Clinical & Molecular DX
MAR 03, 2020
Singapore charges ahead with antibody-based test for COVID-19
Researchers, biotech and pharmaceutical companies are scrambling to put an end to the coronavirus disease (COVID-19) out ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headline ...
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Are COVID-19 Antibody Tests a Back-to-Work Pass?
Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. ...
APR 29, 2020
Immunology
APR 29, 2020
New Immune Cell Discovered in Mammary Ducts
Dubbed “ductal macrophages,” newly discovered immune cells found in breast tissue offer fresh promise for fu ...
Loading Comments...